SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody
The Binding Activity of SARS-CoV-2 Spike RBD Nanobody with SARS-CoV-2-S1-RBD. Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD at 2 μg/ml can bind SARS-CoV-2 Spike RBD Nanobody, the EC50 is 0.8674 ng/ml.
In the Colloidal Gold Immunochromatography Assay detection system, the background of antibody is clean, the detection limit can be as low as 25ng/ml (1.75ng/0.07ml), and the sensitivity is very good.
SARS-CoV-2 Spike RBD Nanobody competed with ACE2-HRP conjugate for binding to SARS-CoV-2-S1-RBD. The binding signal of SARS-CoV-2-S1-RBD and ACE2-HRP conjugate was gradually reduced as the SARS-CoV-2 Spike RBD Nanobody concentrations increased. It indicated that this SARS-CoV-2 Spike RBD Nanobody effectively inhibited the SARS-CoV-2-S1-RBD/ACE2 binding. And the IC50 of this SARS-CoV-2 Spike RBD Nanobody is 1.296 nM.
SARS-CoV-2 Spike RBD Nanobody competitively prevented SARS-CoV-2-S1-RBD from binding to ACE2-HRP conjugate. The inhibition efficacy of the SARS-CoV-2-S1-RBD/ACE2 binding was positively proportionally to the SARS-CoV-2 Spike RBD Nanobody concentrations. It showed that this SARS-CoV-2 Spike RBD Nanobody effectively inhibited the SARS-CoV-2-S1-RBD/ACE2 binding. And the IC50 of this SARS-CoV-2 Spike RBD Nanobody is 0.1074 μg/ml.
SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody
The Binding Activity of SARS-CoV-2 Spike RBD Nanobody with SARS-CoV-2-S1-RBD. Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD at 2 μg/ml can bind SARS-CoV-2 Spike RBD Nanobody, the EC50 is 0.8674 ng/ml.
In the Colloidal Gold Immunochromatography Assay detection system, the background of antibody is clean, the detection limit can be as low as 25ng/ml (1.75ng/0.07ml), and the sensitivity is very good.
SARS-CoV-2 Spike RBD Nanobody competed with ACE2-HRP conjugate for binding to SARS-CoV-2-S1-RBD. The binding signal of SARS-CoV-2-S1-RBD and ACE2-HRP conjugate was gradually reduced as the SARS-CoV-2 Spike RBD Nanobody concentrations increased. It indicated that this SARS-CoV-2 Spike RBD Nanobody effectively inhibited the SARS-CoV-2-S1-RBD/ACE2 binding. And the IC50 of this SARS-CoV-2 Spike RBD Nanobody is 1.296 nM.
SARS-CoV-2 Spike RBD Nanobody competitively prevented SARS-CoV-2-S1-RBD from binding to ACE2-HRP conjugate. The inhibition efficacy of the SARS-CoV-2-S1-RBD/ACE2 binding was positively proportionally to the SARS-CoV-2 Spike RBD Nanobody concentrations. It showed that this SARS-CoV-2 Spike RBD Nanobody effectively inhibited the SARS-CoV-2-S1-RBD/ACE2 binding. And the IC50 of this SARS-CoV-2 Spike RBD Nanobody is 0.1074 μg/ml.

SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody

Vendor: Biomatik

Type: Antibodies

SKU: RAC08029-100UL

$1,149.00 USD
Shipping calculated at checkout.

Available in stock (500)

  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.

Product Overview

Accession number
P0DTC2
Applications
ELISA, GICA, Neutralising
Buffer
{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"0.03% Proclin 300, 50% glycerol, 0.01M PBS, pH 7.4"}]}]}
Clonality
Recombinant Monoclonal
Clone number
A1
Concentration
Lot specific. Please inquire or refer to the datasheet included in the product pouch.
Conjugate
Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.
Description
The SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody is applicable for the following applications: ELISA, GICA, Neutralising.
Expiration
12 months
Format
Liquid
Host
Human
Immunogen
Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa)
Isotype
VHH-Fc
Lead time for package collection
7-11 Business Days
Purification
Affinity chromatography
Quality systems
This product is manufactured at ISO 9001 certified facilities.
Research area
Microbiology
Restrictions
For Research Use Only. Not for use in diagnostic procedures.
Shipping conditions
Ice packs
Species
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
Species reactivity
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
Storage
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Target name
S
Target synonyms
S; S1; S1-RBD; Spike glycoprotein
SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody

SARS-CoV-2 Spike RBD Nanobody Recombinant Antibody

$1,149.00 USD